Acceptability clinical trials

Explore recruiting acceptability clinical trials.

Recruiting acceptability studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acceptability trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Tolerability and acceptance study of two oral hydrocortisone magistral formulations for pediatrics

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A randomized, double-blind, multi-center, placebo-controlled, parallel-group phase 3 study to compare the efficacy, acceptability, and safety of Tranexamic Acid Oral Solution 5% with placebo in the prevention of clinically relevant bleeding events in subjects treated with direct oral anticoagulants or vitamin K antagonists and undergoing a single or multiple tooth extraction

Spain, Hungary, Croatia, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

WOMEN&More: Prospective phase III multi-center open-label study of the efficacy, safety, and acceptability of mifepristone 50 mg once-weekly as a contraceptive

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Open-label single dose trial to evaluate pharmacokinetics, safety, and acceptability/palatability of oveporexton in children from 6 years to less than 18 years of age with narcolepsy type 1 (NT1)

Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

A3921210 - OPEN-LABEL INDUCTION AND MAINTENANCE STUDY OF ORAL CP-690,550 (TOFACITINIB) IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Netherlands, Italy, Spain, Belgium, Poland, Germany +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Open-label single-arm, multicenter clinical trial to evaluate patient acceptability of a new CREON formulation of Pancreas Powder gastro-resistant pellets in patients with cystic fibrosis suffering from pancreatic exocrine insufficiency.

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Acceptability trials by city

Acceptability in Toronto Acceptability in Vancouver Acceptability in Montreal Acceptability in Calgary Acceptability in Edmonton Acceptability in Ottawa Acceptability in Winnipeg Acceptability in Quebec City Acceptability in Hamilton Acceptability in Kitchener Acceptability in London Acceptability in Halifax Acceptability in New York Acceptability in Los Angeles Acceptability in Chicago Acceptability in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease